September 24th, Switzerland

Free Registration, Part of MipTec 2014, Congress Center Basel

Sunday, August 3, 2014

Program Update: New Speakers from Harvard, Rosewell Park and other institutions

The science program of the conference is updated with the new speakers from Harvard, Rosewell Park and other institutions. Please register at the conference website to reserve your seat.

Please download the conference program here:

International Symposium on Geroprotectors: Practical applications of aging research for drug discovery
23.09, Tuesday: Keynotes/General

08.00 - 08.30
Advances in aging biomarkers and drugs with geroprotective properties
Brian Kennedy
Director, CEO
Buck Institute for Aging Research
08.30 - 09.00
New approaches in aging diagnostics and interventions
Charles Cantor
Boston University
09.00 - 9.30
Nir Barzilai
Albert Einstein College of Medicine
ROUND TABLE (Bhupinder Bullar to organize): how can large pharma engage in aging research?
Session I: Predicting the activity of geroprotective drugs: in-silico screening, omics data analysis and rational drug design; Session Chair: Joao Pedro Megalhaes, PhD
10.30 - 11.00
Novel methods for selecting targeted drugs for personalized medicine in oncology
Anton Buzdin
President, CEO
Pathway Pharmaceuticals
11.00 - 11.30
Bioinformatic analysis of the “omics” data from long-lived animals for geroprotector discovery
Joao Pedro De Magalhaes
Lab Head
University of Liverpool
11.30 - 12.00
In silico screening for novel drugs with geroprotective properties
Alexander Zhavoronkov
The Biogerontology Research Foundation

Dr. Jörg Reinhardt
Session II: Drugs with the potential geroprotective properties
Session Chair: TBD

14.30 - 15.00
Using novel isotopically-fortified organic compounds to slow down the aging processes
and treat age-related diseases
Robert Molinari
Retrotope, Inc
15.00 - 15.30
Advances in the Advanced Glycation Endproduct (AGE) breakers
William Bains
Head of the SENS Laboratory
15.30 - 16.00
Overview of the possible geroprotectors
Sven Bulterijs
Post-grad researcher
Yale University
16.00 - 16.30
Coffee Break

16.30 - 17.00
Applied Epigenetics of Aging and Longevity
Olga Kovalchuk
Professor, Lab Head
University of Lethbridge
24.09, Wednesday: Keynotes/General

08.00 - 08.30
Rapamycin and other geroprotectors
Mikhail Blagosklonny
Professor, editor-in-chief of Aging
Rosewell Park, NY
08.30 - 09.00
Blanka Rogina
Director Genetics & Developmental Biology Graduate Program
University of Connecticut
09.00 - 09.30
James Kirkland
Mayo Clinic
09.30 - 10.00
How to Solve Genetic Disease on a Population Scale
Barry Merriman
Professor/ Lead System Architect, CSO
UCLA/Thermo Fisher Scientific
10.00 - 10.30
Coffee Break

Session III: Aging Biomarkers: how do we measure aging and geroprotective efficacy
Session Chair: Alexander Bürkle, PhD
10.30 - 11.00
Lessons learned from the EU FP7 MARKAGE Project
Alexander Bürkle
Professor, MARK-AGE Co-ordinator
University of Konstanz
Comparative genomics of aging and longevity
Vadim Gladyshev
Professor, Department of Medicine, Harvard Medical School
Director of Redox Medicine, Brigham And Women's Hospital
11.00 - 11.30
Gene expression patterns in progeria and age-related diseases
Antonei Benjamin Csoka
Assoc. Professor
Howard University
11.30 - 12.00
Genetic and Epigenetic Biomarkers of Aging
Alexey A Moskalev
Professor, head of the laboratory
Moscow Institute of Physics and Technology

Prof. Patrick Aebischer
Ecole Polytechnique Fédérale de Lausanne (EPFL)
Session IV: Trends in Aging Research for Drug Discovery
Session Chair: Richard Faragher, PhD
14.30 - 15.00
Ageing Research and Regenerative Medicine Industry Outlook
Charles Groome and Geoffrey Furlonger
Head of Communications
Aging Analytics
15.00 - 15.30
Industry Partnerships for Ageing Research
David Brindley
Research Fellow in Cell Therapy Commercialization / Researcher
Harvard Stem Cell Institute / University of Oxford, NDORMS
15.30 - 16.00
Big Data in Biomedicine: Applying machine learning to predict the outcomes of biomedical research projects
Dmitry Kaminskiy
Director, Senior Partner
Deep Knowledge Ventures
16.00 - 16.30
Coffee Break

16.30 - 17.00
Richard Faragher
University of Brighton
Backup keynote speaker (23 or 24)

New drug discovery: AK-1 for radioprotection, AK-2 for antiviral and AK-3 for anti-aging
Grace Wong


Post a Comment

Note: Only a member of this blog may post a comment.